A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk
β Scribed by Christopher A. Haiman; Susan E. Hankinson; Donna Spiegelman; Immaculata De Vivo; Graham A. Colditz; Walter C. Willett; Frank E. Speizer; David J. Hunter
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 75 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Long-term exposure to oestrogens is a well-recognised risk factor for breast cancer, whereas little is known about the influence of polymorphisms of genes involved in oestrogen biosynthesis and metabolism. A candidate, containing a single bp polymorphism, T8C, (designated, A2 allele), might be the C
CYP17 encodes the enzyme cytochrome P-450c17β£, which mediates both 17β£-hydroxylase and 17,20-lyase in the steroid biosynthesis pathway. A polymorphism in the 5 promoter region of the CYP17 gene has been described. Steroid hormones, especially androgens, are believed to play a key role in the etiolog
Apolipoprotein E (apoE) is a polymorphic gene involved in lipid metabolism with three common variant alleles (epsilon2, epsilon3, and epsilon4). The epsilon4 allele has been associated with elevated levels of cholesterol as well as greater risk of coronary heart disease and Alzheimer's disease. In t
Endogenous estrogen and tobacco smoke are putative risk factors for breast cancer. The genes CYP1A1 and 1B1 are involved in the metabolism of endogenous estrogen as well as of tobacco specific compounds. In a German population based case-control study of premenopausal breast cancer risk with 394 cas
Experimental and clinical evidence suggests that breast neoplasia appears to be a hormone-dependent process that may also be influenced by dietary factors in many women. Conflicting reports on the relationship between exogenous hormones and the development, progression, and recurrence of breast canc